Thus, DPP4 inhibitors act to prevent inactivation of and prolong the duration of action of incretins, which in turn helps to correct the defective insulin and glucagon secretion that marks type 2 diabetes (see below)
Soluble fiber, in particular, promotes satiety and helps reduce cravings between meals amplifying its benefits
Regarding berberines lipid-lowering effect, there is evidence that berberine shunts the body's lipid production through the AMP-activated protein kinase
Pharmacotherapy for non-alcoholic fatty liver disease: Emerging targets and drug candidates
Keywords: GLP-1 receptor agonists, obesity, weight loss, non-diabetic patients, cardiovascular outcomes, cost-effectiveness Introduction Obesity is a chronic disease with high prevalence and associated comorbidities, making it a growing global concern [7] [8]